Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-24 Lambert Nicole President, Myriad Oncology, Grant or award +29,556 135,768
2021-03-24 Riggsbee Richard Bryan Chief Financial Officer Grant or award +32,774 339,925
2021-03-24 Hart Jayne B. Chief People Officer Grant or award +13,326 80,128
2021-03-24 Verratti Mark President, Myriad Neuroscience Grant or award +15,441 157,130
2021-03-24 LANCHBURY JERRY S Chief Scientific Officer Grant or award +19,347 265,922
2021-03-24 DIAZ PAUL J President and CEO Grant or award +159,915 458,869
2021-02-18 Haas Kevin Richard SVP Technology Grant or award +10,000 42,443
2021-02-18 Ancona Margaret SVP Enterprise Transformation Grant or award +30,000 30,000
2021-02-18 Riggsbee Richard Bryan Chief Financial Officer Returned to the company −11,175 $29.69 $332K 307,151
2021-02-16 LANCHBURY JERRY S Chief Scientific Officer Exercise or conversion +74,445 $18.00 $1.3M 321,020
2021-02-16 LANCHBURY JERRY S Chief Scientific Officer Sale −74,445 $29.71 $2.2M 246,575
2021-02-16 LANCHBURY JERRY S Chief Scientific Officer Exercise or conversion +5,555 $18.00 $100K 252,130
2021-02-16 LANCHBURY JERRY S Chief Scientific Officer Sale −5,555 $29.71 $165K 246,575
2021-02-16 LANCHBURY JERRY S Chief Scientific Officer Exercise or conversion · Incentive Stock Option (right to buy) −5,555 0
2021-02-16 LANCHBURY JERRY S Chief Scientific Officer Exercise or conversion · Non-Qualified Stock Option (right to buy) −74,445 0
2021-01-08 Parkinson Paul EVP Strategy and Innovation Sale −11,824 $25.00 $296K 76,746
2020-12-04 Newcomer Lee Nisley Director Grant or award +15,889 27,576
2020-12-04 Phanstiel S. Louise Director Grant or award +15,889 82,679
2020-12-04 DREISMANN HEINRICH Director Grant or award +15,889 70,679
2020-12-04 LANGER DENNIS Director Grant or award +15,889 76,679

Page 29 of 35 · 689 trades